JPMORGAN CHASE & CO - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$83,667,000
+25964.5%
385,738
+13795.5%
0.01%
Q4 2020$321,000
-51.0%
2,776
-58.5%
0.00%
Q3 2020$655,000
-9.9%
6,686
+13.0%
0.00%
Q2 2020$727,000
+48.4%
5,919
+5.9%
0.00%
Q1 2020$490,000
-27.4%
5,588
-13.4%
0.00%
Q4 2019$675,000
+13.3%
6,454
+24.5%
0.00%
Q3 2019$596,000
-64.7%
5,184
-47.8%
0.00%
Q2 2019$1,690,000
+144.6%
9,927
+142.1%
0.00%
Q1 2019$691,000
+11.5%
4,101
-35.6%
0.00%
Q4 2018$620,000
+221.2%
6,371
+467.3%
0.00%
Q3 2018$193,000
-93.9%
1,123
-95.1%
0.00%
-100.0%
Q2 2018$3,174,000
+34.3%
22,746
+8.4%
0.00%0.0%
Q1 2018$2,364,000
+3712.9%
20,984
+4345.8%
0.00%
Q4 2017$62,000
-93.7%
472
-94.6%
0.00%
Q3 2017$985,000
+1514.8%
8,772
+1359.6%
0.00%
Q2 2017$61,000
-95.6%
601
-94.8%
0.00%
Q1 2017$1,401,000
-38.3%
11,595
-43.0%
0.00%
-100.0%
Q4 2016$2,272,000
+121.2%
20,337
+163.0%
0.00%
Q3 2016$1,027,000
-84.4%
7,733
-89.2%
0.00%
-100.0%
Q2 2016$6,573,000
-12.4%
71,784
-31.0%
0.00%0.0%
Q1 2016$7,507,000
+39.3%
104,046
+34.0%
0.00%
+100.0%
Q4 2015$5,391,000
-15.2%
77,641
+11.6%
0.00%
-50.0%
Q3 2015$6,358,000
-4.4%
69,587
+28.6%
0.00%0.0%
Q2 2015$6,648,000
+151.5%
54,124
+86.6%
0.00%
+100.0%
Q1 2015$2,643,000
+450.6%
29,007
+309.6%
0.00%
Q4 2014$480,0007,0820.00%
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders